Expression of the Retinoblastoma Tumor Suppressor Gene (RB-1) in Acute Leukemia

Leukemia and Lymphoma

Volumn 28, Issue 42067, 1998, Pages 275-283

  Sauerbrey, Axel ^a   Stammler, Gerd ^b   Zintl, Felix ^a   Volm, Manfred ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

acute leukemia; prognosis; Retinoblastoma gene; tumor suppressor gene

Indexed keywords

RETINOBLASTOMA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; GENE REPRESSION; HUMAN; MONOCYTE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TUMOR SUPPRESSOR GENE;

ADULT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; RETINOBLASTOMA PROTEIN;

EID: 0031881270     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199809092683     Document Type: Article

References (37)

1. Marshall C. J. Tumor suppressor genes. Cell 1991; 64: 313 – 326
2. Vramus H. E., Lowell C. A. Cancer genes and hematopoiesis. Blood 1994; 83: 5 – 9
3. Yarbo J. W. Oncogenes and cancer suppressor genes. Semin. Oncol. 1992; 8: 30 – 39
4. Godbout R., Dryja T. P., Squire J., Gallie B. L., Phillips R. A. Somatic inactivation of genes on chromosome 13 is a common event in both hereditary and non-hereditary retinoblastoma tumors. Nature 1983; 304: 451 – 455
5. Friend S. H., Bernards R., Rogelj S., Weinberg R. A., Rapaport J. M., Albert D. M., Dryja T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643 – 649
6. Toguchida J., Ishizak K., Sasaki M. S., Ikenaga M., Sugimoto M., Kotoura Y., Yamamuro T. Chromosomal reorganization for the expression of recessive mutation of the retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res. 1988; 48: 3939 – 3943
7. Benedict W. F., Xu H. J., Takahashi R. Role of the retinoblastoma gene in the initiation and progression of human cancer. J. Clin. Invest. 1990; 85: 988 – 993
8. Presti J. C., Reuter V. C., Galan T., Fai W. R., Cordon-Cardo C. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res. 1991; 51: 5405 – 5409
9. Pietilainen T., Lipponen P., Aaltomaa S., Eskelinen M., Kosma V. M., Syrjanen K. Expression of retinoblastoma gene protein (Rb) in breast cancer as related to established prognostic factors and survival. Eur. J. Cancer 1995; 31: 329 – 333
10. Cance W. G., Brennan M. F., Dudas M. E., Huang C.-M., Cordon-Cardo C. Alterated expression of the retinoblastoma gene product in human sarcomas. New. Engl. J. Med 1990; 323: 1457 – 1459
11. Zuckerberg L. R., Benedict W. F., Arnold A., Dyson N., Harlow E., Harris L. H. Expression of the retinoblastoma protein in low-grade B-cell lymphoma: Relationship to cyclin D1. Blood, 88: 268 – 276
12. Weide R., Tiemann M., Pfliiger K.-H., Koppler H., Parvizl B., Wacker H. H., Kreipe H. H., Havemann K., Parwaresch M. R. Alterated expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas. Leukemia 1994; 8: 97 – 101
13. Paggi M. G., Defrabitiis P., Bonetto F., Amadio L., Santarelli G., Spadea A., Gentile F. P., Floridi A., Felsani A. The retinoblastoma gene product in acute myeloid leukemia. A possible involvement in acute promyelo-cytic leukemia. Cancer Res. 1995; 55: 4552 – 4556
14. Ahuja H. G., Jat P. S., Foti A., Bar-Eli M., Cline M. J. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 1991; 78: 3259 – 3268
15. Kornblau S. M., Xu H.-J., del Giglio A., Hu S. X., Zhang W., Calvert L., Beran M., Estey E., Andreeff M., Trujillo J., Cork M. A., Smith T. L., Benedict W. F., Deisseroth A. B. Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res. 1992; 52: 4587 – 4590
16. Kornblau S. M., Xu H. J. X., Zhang W., Hu S. X., Beran M., Smith T. L., Hester J., Estey E., Benedict W. F., Deisseroth A. B. Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood 1994; 84: 256 – 261
17. Tang J. L., Yeh S. H., Chen P. J., Lin M. T., Tien H.-F., Chen Y. C. Inactivation of the retinoblastoma gene in acute myelogenous leukemia. Br. J. Haematol. 1992; 82: 502 – 507
18. Sauerbrey A., Stammler G., Zintl F., Volm M. Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukemia. Br. J. Haematol 1996; 94: 99 – 104
19. Hangaishi A., Ogawa S., Imamura N., Miyawaki S., Miura Y., Uike N., Shimazaki C., Emi N., Takeyama K., Hirosawa S., Kamada N., Kobayashi Y., Takemoto Y., Kitani T., Toyama K., Ohtake S., Yazaki Y., Ueda R., Hirai H. Inactivation of multiple tumor suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid malignancies. Blood 1996; 87: 4949 – 4958
20. Horton L. E., Qian Y., Templeton D. J. G1 cyclin controls the retinoblastoma gene product regulation activity via upstream mechanisms. Cell Growth Differ. 1995; 6: 395 – 407
21. Goodrich D. W., Wang N. P., Qian Y. W., Lee E. Y. H. P., Lee W. H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 1991; 67: 293 – 302
22. Lipponen P., Eskelinen M., Syrjanen K. Expression of tumor-suppressor gene Rb, apoptosis-suppress-ing protein Bcl-2 and c-Myc have no independent prognostic value in renal adenocarcinoma. Br. J. Cancer 1995; 71: 863 – 867
23. Udvadia A. J., Templeton D. J., Horowitz J. M. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: Superactivation by Rb requires amino acids necessary for growth suppression. Proceedings of the National Academy of Sciences of the United States of America 1995; 92: 3953 – 3957
24. Robbins P. D., Horowitz J. M., Mulligan R. C. Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature 1990; 346: 668 – 672
25. Lukas J., Bartkova J., Rohde M., Strauss M., Bartek J. Cyclin Dl is dispensable for GI control in retinoblastoma gene-deficient cells independently of cdk4 activity. Mol. Cell Biol. 1995; 15: 2600 – 2611
26. Whyte P., Buchkovich K. J., Horowitz J. M., Friend S. H., Raybuck M., Weinberg R. A., Harlow E. Association between an oncogene and an anti-oncogene: The adenovirus E1 A proteins bind to the retinoblastoma gene product. Nature 1988; 334: 124 – 129
27. De Caprio J. A., Ludlow J. W., Figge J., Shew J.-Y., Huang C. M., Lee W.-H., Marsilio E., Paucha E., Livingston D. M. SV 40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275 – 280
28. Zintl F., Malke H., Reimann M., Domula M., Dörffel W., Eggers G., Exadaktylos P., Hilgenfeld E., Kotte W., Krause I., Kunert W., Mittler U., Mobius D., Reddemann H., Weinmann G., Wei???bach G. Results with ran-domized BFM adopted studies for ALL therapy in childhood in east German countries. Acute Leukemias IV: Prognostic factors, T. Büchner, G. Schellong, W. Hiddemann, J. Urbanitz, J. Ritter. Springer Verlag, Berlin Heidelberg 1993; 179 – 186
29. Tsai T., Davalath S., Rankin C., Radich J. P., Head D., Appelbaum F. R., Boldt D. H. Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies. Leukemia 1996; 10: 1901 – 1910
30. Ginsberg A. M., Raffeld M., Cossman J. Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood 1991; 11: 833 – 840
31. Weide R., Parviz B., Plüge K. H., Havemann K. Alterated expression of the human retinoblastoma gene in monocytic leukemias. Br. J. Haematol 1993; 83: 428 – 432
32. Neubauer A., de Kant E., Rochlitz C., Laser J., Zanetta A. M., Gallardo J., Oertel J., Herrmann R., Huhn D. Altered expression of the retinoblastoma susceptibility gene in chronic lymphocytic leukemia. Br. J. Haematol. 1993; 85: 498 – 503
33. Corradini P., Inghirami G., Astolfi M., Ladetto M., Voena C., Ballerini P., Gu W., Nilsson K., Knowles D. M., Boccadoro M., Pileri A., Dalla-Favera R. Inactivation of tumor suppressor genes, p53 and Rbl, in plasma cell dyscrasias. leukemia 1994; 8: 758 – 767
34. Gorlick R., Goker E., Trippett T., Waltham M., Benerjee D., Bertino J. R. Intrinsic and acquired resistance to methotrexate in acute leukemia. N. Engl. J. Med. 1996; 335: 1041 – 1048
35. Volm M., Mattern J., Samsel B. Relationship of inherited resistance to doxorubicin, proliferative activity and expression of p-glycoprotein 170, and glutathione S-trans-ferase π in human lung tumors. Cancer 1992; 70: 764 – 769
36. Volm M., Sauerbrey A., Stammler G., Zintl F. Detection of Fos, Jun and Ras in newly diagnosed childhood acute lymphoblastic leukemia by immunocytochemistry and PCR. Int. J. Oncology 1994; 4: 1251 – 1256
37. Sauerbrey A., Zintl F., Volm M. P-glycoprotein and glutathione S-transferase π in childhood acute lymphoblastic leukemia. Br. J. Cancer 1994; 70: 1144 – 1149